Edward W. Rowe

Bristol, ENG BS105NB, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825.

Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825.

Journal: Cancers
Published: December 04, 2025

The Prostate cancer-Exercise and Metformin randomised controlled feasibility Trial (Pre-EMpT) in men following active surveillance, radical prostatectomy and radiotherapy.

The Prostate cancer-Exercise and Metformin randomised controlled feasibility Trial (Pre-EMpT) in men following active surveillance, radical prostatectomy and radiotherapy.

Journal: Pilot and feasibility studies
Published: July 16, 2024

National audit of patient reported experience of radical cystectomy for bladder cancer pathways.

National audit of patient reported experience of radical cystectomy for bladder cancer pathways.

Journal: BJUI compass
Published: June 10, 2024

Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease.

Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease.

Journal: Clinical science (London, England : 1979)
Published: May 22, 2024

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.

Journal: NEJM evidence
Published: February 06, 2024

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Journal: The New England journal of medicine
Published: March 13, 2023

Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.

Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.

Journal: Oncotarget
Published: January 26, 2023

Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer.

Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer.

Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Published: January 13, 2023

Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative study.

Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative study.

Journal: BMJ open
Published: June 29, 2022

The impact of cardiopulmonary exercise testing (CPET) and Charlson comorbidity index (CCI) in a large contemporary cohort of patients undergoing robot-assisted radical cystectomy and intracorporeal urinary diversion (RARC-ICUD).

The impact of cardiopulmonary exercise testing (CPET) and Charlson comorbidity index (CCI) in a large contemporary cohort of patients undergoing robot-assisted radical cystectomy and intracorporeal urinary diversion (RARC-ICUD).

Journal: BJUI compass
Published: May 26, 2022

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.

Journal: JAMA
Published: May 15, 2022

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).

Journal: BJU international
Published: December 15, 2021
Showing 1-12 of 51

Last Updated: 09/26/2026